BioAdvance News

Ceptaris Receives FDA Approval for VALCHLOR(TM) (mechlorethamine) Gel

By WebmasterAugust 25, 2013November 1st, 2024No Comments

Ceptaris Receives FDA Approval for VALCHLOR(TM) (mechlorethamine) Gel
Read more here

Previous PostGalderma Receives FDA Approval of Mirvaso®
Next PostActelion enters into an agreement to acquire privately-held Ceptaris Therapeutics